查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024571

晶片器官市場報告：按產品、類型、應用、最終用途和地區分類（2026-2034 年）

Organ-on-chip Market Report by Offering, Type, Application, End Use, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球晶片器官市場規模達9,820萬美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到7.279億美元，2026年至2034年的複合年成長率（CAGR）為24.19%。推動該市場成長的因素包括：晶片器官在促進藥物研發方面發揮的關鍵作用；技術進步、合作研究以及監管機構和倫理部門日益重視透過更精準、更人道的替代方案來減少動物實驗。

晶片器官市場分析

  • 市場主要促進因素：由於製藥和生物技術領域對更準確、更符合倫理的調查方法的需求，晶片器官市場正在迅速擴張。
  • 關鍵市場趨勢：3D生物列印和微流體等技術進步正在革新晶片器官模型，擴大其準確性和適用範圍。
  • 區域趨勢：北美市場領先，這得益於其強大的研發基礎設施和積極的監管措施。然而，隨著生物技術投資的增加，歐洲和亞太地區正在迅速追趕。
  • 競爭格局：晶片器官產業的主要市場參與企業包括 Allevi Inc.、Altis Biosystems、AxoSim、BiomimX Srl、Elveflow、Emulate Inc.、InSphero、MIMETAS、Nortis Inc.、TARA Biosystems Inc. 和 TissUse GmbH。
  • 挑戰與機會：雖然技術複雜性和高成本仍然是挑戰，但向個人化醫療的轉變和多器官模型的開發為晶片器官市場帶來了巨大的機會。

晶片器官市場的發展趨勢

加強藥物研發

器官晶片技術因其能夠顯著加速藥物發現和新藥研發，而擁有巨大的市場潛力。與傳統的2D細胞培養和動物模型相比，該技術能夠更精確地模擬人體器官的反應，有助於縮短藥物測試和研發所需的時間。因此，這項創新技術展現出無與倫比的預測準確性，這對於降低藥物發現的時間、成本和失敗率至關重要。正因如此，製藥公司開始將器官晶片技術融入其研發流程，以彌合這一差距，從而推動個人化和精準醫療的發展，並提高治療成功率。此外，這項轉變有望加快許多藥物的核准，並有助於部分抵消那些在最後階段失敗的藥物所帶來的成本。

技術創新與合作

持續的技術進步是推動器官晶片產業轉型的主要動力之一。能夠同時模擬多個器官系統功能的晶片的出現，提供了更全面的分析工具，涵蓋了臨床前測試的早期階段，並使臨床試驗更貼近公眾。目前的創新包括引入微流體技術、在多維結構中3D列印細胞以及自動化影像分析，這些技術旨在提高器官晶片系統的功能性和可擴展性。此外，生物技術公司、研究機構和技術專家之間的合作正在為跨學科研究創造策略環境，從而推動該領域的快速發展。這種合作不僅對於克服技術挑戰和改進應用至關重要，而且對於加速毒性測試、疾病建模和精準醫療等各個領域的發展也至關重要。例如，器官晶片（OOC）技術透過提供更精確的預測模型，正在革新傳統的體外ADME和毒性測試，並以預計15%的年成長率推動藥物研發。整合多器官系統的晶片器官（OOC）平台正在推動藥物動力學和動態研究，並揭示藥物分子的時間依賴性和劑量依賴性作用。預計到2025年，晶片器官市場規模將達到2.2億美元。這項先進技術憑藉其精確的流動控制和快速的樣品處理能力，優於傳統的2D培養方法，使其成為療效測試和毒性評估的關鍵工具。

法規和道德規範的變化

對動物實驗倫理問題的關注以及日益嚴格的監管，進一步推動了器官晶片產業的發展。世界各地的研究機構和部門開始意識到，與動物模型相比，這些技術能夠提供更相關的數據。美國食品藥物管理局（FDA）的器官晶片計畫等舉措推動了這一趨勢。因此，這一轉變與公眾和政府對動物友善研究方法的日益成長的需求不謀而合。器官晶片技術在倫理上是合理的，因為它不僅符合更高的監管標準，而且有助於推動以人為本、科學先進的研究方法模式轉移。這種倫理立場在推動器官晶片設備在研發領域的廣泛核准方面發揮著越來越重要的作用。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球晶片器官市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品/服務分類

  • 產品
  • 服務

第7章 市場區隔：依類型

  • 肝
  • 心
  • 肺
  • 腎
  • 其他

第8章 市場區隔：依應用領域分類

  • 生理模型的發展
  • 藥物發現
  • 毒理學研究

第9章 市場區隔：依最終用途分類

  • 製藥和生物技術公司
  • 學術研究機構
  • 化妝品產業
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Allevi Inc.
    • Altis Biosystems
    • AxoSim
    • BiomimX Srl
    • Elveflow
    • Emulate Inc.
    • InSphero
    • MIMETAS
    • Nortis Inc.
    • TARA Biosystems Inc.
    • TissUse GmbH
Product Code: SR112026A5498

The global organ-on-chip market size reached USD 98.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 727.9 Million by 2034, exhibiting a growth rate (CAGR) of 24.19% during 2026-2034. The market is driven by its critical role in enhancing pharmaceutical R&D, stimulated by technological advancements, collaborative efforts, and increasing regulatory and ethical emphasis on reducing animal testing through more accurate and humane alternatives in medical research.

ORGAN-ON-CHIP MARKET ANALYSIS :

  • Major Market Drivers: The organ-on-chip market is expanding rapidly, driven by the need for more accurate and ethical research methods in pharmaceuticals and biotechnology.
  • Key Market Trends: Technological advancements such as 3D bioprinting and microfluidics are revolutionizing organ-on-chip models, increasing their accuracy and applicability.
  • Geographical Trends: North America leads the market, supported by robust research infrastructure and proactive regulatory policies; however, Europe and Asia-Pacific are quickly catching up due to rising investments in biotech.
  • Competitive Landscape: Some of the major market players in the organ-on-chip industry include Allevi Inc., Altis Biosystems, AxoSim, BiomimX S.r.l., Elveflow, Emulate Inc., InSphero, MIMETAS, Nortis Inc., TARA Biosystems Inc., TissUse GmbH., etc. among many others.
  • Challenges and Opportunities: While technological complexities and high costs pose challenges, the growing shift towards personalized medicine and the expansion into multi-organ models present significant organ-on-chip market opportunities.

ORGAN-ON-CHIP MARKET TRENDS:

Pharmaceutical Research and Development Enhancement

The organ-on-chip market potential is greatly increased because it can dramatically enhance drug development and discovery. These techniques provide a more precise simulation of how human organs respond compared to conventional 2D cell cultures, and animal models and hence they help to reduce the time taken in drug testing and development. This innovation, thus, offers unparalleled prediction accuracy, essential for decreasing the duration, cost, and failure rates during drug discovery. As a result, pharmaceutical organizations are starting to integrate organ-on-chip technologies into their R&D processes to narrow the gap, leading to the advancement of personalized and precise medicine and higher therapeutic success rates. Besides, this shift produces the prospect of many quick drug approvals which partly cover the cost of those that failed in the final stage .

Technological Innovations and Collaborations

Continuous technological advancements are one of the major stimuli that are transforming the organ-on-chip industry. The manufacturing of chips capable of replicating several organ systems' functionalities at the same time is a more complete analysis tool, covering the first stage of preclinical testing and bringing clinical trials closer to the population. The inventions being made include incorporating microfluidics, 3D printing of cells within multi-dimensional structures, and automated imaging which allows for better functionality and scalability of organ-on-chip systems. Furthermore, associations between biotech firms, research institutions, and technology specialists have formed a strategic environment for cross-disciplinary studies that, in turn, results in fast improvements in this field. These collaborations are vital to overcoming technical issues and improving applications, as well as promoting various sectors like toxic things testing, disease modeling, and precision medicine. For instance, Organ-on-chip (OOC) technology revolutionizes traditional in vitro ADME and toxicity tests by offering a more accurate predictive model, enhancing drug development with an estimated growth rate of 15% annually. Incorporating multi-organ systems, OOC platforms enhance pharmacokinetic and pharmacodynamic studies, providing insights into the time and dose-dependent effects of drug molecules. Based on organ-on chip market revenue, these advanced technology, projected to reach a market size of $220 million by 2025, outperforms conventional 2D cultures with its precise flow control and rapid sample processing, making it essential for efficacy studies and toxicity evaluations.

Regulatory and Ethical Shifts

Ethical issues and stricter regulations concerning the application of animals in scientific research are additionally stimulating the growth of the organ-on-chip industry. Agencies and departments all around the world are coming to recognize the value of these technologies in providing more relevant data than animal models. This is what is being promoted by endeavors such as the USFDA's Organ-on-Chip program. Therefore, this transition is consistent with the growing public and governmental push for animal-friendly investigation techniques. Organ-on-chip technologies, not only qualifying for higher regulatory standards, are also ethically warranted, since they can promote a paradigm shift towards more human and scientifically advanced research techniques. This ethical standpoint is getting an increasing role in wider approval for organ-on-chip devices to be used in research and development.

ORGAN-ON-CHIP MARKET SEGMENTATION:

Breakup by Offering:

  • Products
  • Services

Breakup by Type:

  • Liver
  • Heart
  • Lung
  • Kidney
  • Others

Lung holds the largest share of the industry

According to the organ-on-chip market trend, the lung-on-chip is the most expanded due to its high application in respiratory studies and drug discovery. This technology is suitable for modeling the complex structure and function of the human lung to provide a dynamic platform for respiratory diseases, drug response evaluation, and inhaled substances toxicity assessment. Its role in the process of speeding up the development of personalized therapies for different lung diseases, such as asthma and chronic obstructive pulmonary disorder (COPD), is truly emphasized. Lung-on-chip model leads to a more reliable and ethical replacement of animal testing, hence the assurance of drug efficacy and safety to the authorities, which is a prerequisite for successful market entry. This shifts drug discovery and biotechnology to the leadership role in this area, continuing and increasing the organ-on-chip market share.

Breakup by Application:

  • Physiological Model Development
  • Drug Discovery
  • Toxicology Research

Drug discovery represents the leading market segment

As per the organ-on-chip market overview, drug discovery is the largest segment for all phases of drug development. This is because the segment has such a key transforming way of developing the processes of pharmaceutical products. Organ-on-chip systems can mimic human organs' responses under various conditions in a way that otherwise would be impossible, allowing scientists to do early screenings for a prospective drug. This ability of the computer successfully enables us to estimate how those drugs will be affected by the human tissues, which in turn creates a step in the right direction of the efficacy and safety test process. It therefore follows that the drug discovery time frame is greatly shortened, and the clinical trial costs and risk become lower. The broadening utilization of these technologies by a pharmaceutical company indicates a great opportunity in this area to make drug hunting faster but not only, less costly and in line with better regulatory requirements for safety and effectiveness.

Breakup by End Use:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Cosmetics Industry
  • Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

The pharmaceutical and biotechnology companies account for the largest market share. This superiority is mainly caused by the increased usage of micro-organ models in the drug discovery and development phases of these industries. The organ-on-chip companies use technology to copy human body functions and its responses to a higher level than conventional methods which use animal experimenting and 2D cell cultures. Improved capacities to match human organ functions and interact in a laboratory setting provide better detection of drug efficacy and toxicity at an early stage of development. It not only improves the prospects of success in the clinical trials but also decreases the time and cost involved in the process of commercialization of a new drug. Being that pharmaceutical and biotechnology company are constantly in search of inventive ways that will accelerate the research and development process, the utilization of organ-on-chip technologies is anticipated to keep increasing, therefore making this segment the largest one in the market and creating a positive organ-on-chip market outlook.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest organ-on-chip market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for organ-on-chip.

According to the organ-on-chip market report, the largest segment here is North America. This superiority comes from a strong research infrastructure, good funding of the biotechnology and pharmaceutical industry, and the exemplary support given to innovative healthcare solutions by the government and the private sector North American confident leadership in the market is further fortified by the existence of leading universities and research institutions that always drive the frontiers of the medical fieldwork with the Increasing organ-on-chip demand in technologies. Other than that, the area fosters an already existing regulatory framework that provides high adoption opportunities of cutting-edge tools for drug development and personalized medicine which include organ-on-chip. The dominance of these economic entities is what pushes other players to innovate the development and deployment of such technologies contribute to the regional prominence in the global market. This active and advanced veterinary system provides organ-on-chip market growth models which makes these models in use in medical research and pharmaceutical testing.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the organ-on-chip industry include:

  • Allevi Inc.
  • Altis Biosystems
  • AxoSim
  • BiomimX S.r.l.
  • Elveflow
  • Emulate Inc.
  • InSphero
  • MIMETAS
  • Nortis Inc.
  • TARA Biosystems Inc.
  • TissUse GmbH

Major players in the organ-on-chip industry keep improving and broadening their technological arsenals by different means, including research and development, cooperation, and mergers and acquisitions. According to organ-on-chip recent developments businesses aim to develop more specific and versatile organ-on-chip models capable of simulating human physiology more precisely for drug testing and disease modeling. The pragmatic cooperation is responsible for the quick product commercialization of new technologies in addition to broadening the microfluidic systems' application scope in personalized medicine, safety pharmacology, and complex biological research, which consequently fortifies their market positions. According to the organ-on-chip market forecast, strategic collaborations with pharmaceutical companies, academic institutions, and technology providers are creating a positive outlook for the market.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Organ-on-chip Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Offering

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Liver
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Heart
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Lung
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Kidney
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Physiological Model Development
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Discovery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Toxicology Research
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cosmetics Industry
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allevi Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Altis Biosystems
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 AxoSim
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 BiomimX S.r.l.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Elveflow
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Emulate Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 InSphero
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 MIMETAS
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Nortis Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 TARA Biosystems Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 TissUse GmbH
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Organ-on-chip Market: Major Drivers and Challenges
  • Figure 2: Global: Organ-on-chip Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Organ-on-chip Market: Breakup by Offering (in %), 2025
  • Figure 5: Global: Organ-on-chip Market: Breakup by Type (in %), 2025
  • Figure 6: Global: Organ-on-chip Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Organ-on-chip Market: Breakup by End Use (in %), 2025
  • Figure 8: Global: Organ-on-chip Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Organ-on-chip (Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Organ-on-chip (Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Organ-on-chip (Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Organ-on-chip (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Organ-on-chip (Liver) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Organ-on-chip (Liver) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Organ-on-chip (Heart) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Organ-on-chip (Heart) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Organ-on-chip (Lung) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Organ-on-chip (Lung) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Organ-on-chip (Kidney) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Organ-on-chip (Kidney) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Organ-on-chip (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Organ-on-chip (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Organ-on-chip (Physiological Model Development) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Organ-on-chip (Physiological Model Development) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Organ-on-chip (Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Organ-on-chip (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Organ-on-chip (Toxicology Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Organ-on-chip (Toxicology Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Organ-on-chip (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Organ-on-chip (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Organ-on-chip (Academic and Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Organ-on-chip (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Organ-on-chip (Cosmetics Industry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Organ-on-chip (Cosmetics Industry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Organ-on-chip (Other End Uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Organ-on-chip (Other End Uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: North America: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: North America: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: United States: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: United States: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Canada: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Canada: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Asia-Pacific: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Asia-Pacific: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: China: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: China: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Japan: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Japan: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: India: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: India: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: South Korea: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: South Korea: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Australia: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Australia: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Indonesia: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Indonesia: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Others: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Others: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Europe: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Europe: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Germany: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Germany: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: France: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: France: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: United Kingdom: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: United Kingdom: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Italy: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Italy: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Spain: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Spain: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Russia: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Russia: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Latin America: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Latin America: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Brazil: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Brazil: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Mexico: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Mexico: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Others: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Others: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Middle East and Africa: Organ-on-chip Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Middle East and Africa: Organ-on-chip Market: Breakup by Country (in %), 2025
  • Figure 85: Middle East and Africa: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Global: Organ-on-chip Industry: SWOT Analysis
  • Figure 87: Global: Organ-on-chip Industry: Value Chain Analysis
  • Figure 88: Global: Organ-on-chip Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Organ-on-chip Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Organ-on-chip Market Forecast: Breakup by Offering (in Million USD), 2026-2034
  • Table 3: Global: Organ-on-chip Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 4: Global: Organ-on-chip Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Organ-on-chip Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 6: Global: Organ-on-chip Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Organ-on-chip Market: Competitive Structure
  • Table 8: Global: Organ-on-chip Market: Key Players